Yannick Kaiser

1.9k total citations · 2 hit papers
34 papers, 1.2k citations indexed

About

Yannick Kaiser is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Yannick Kaiser has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Yannick Kaiser's work include Lipoproteins and Cardiovascular Health (15 papers), Cardiac Valve Diseases and Treatments (9 papers) and Cardiac Imaging and Diagnostics (9 papers). Yannick Kaiser is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Cardiac Valve Diseases and Treatments (9 papers) and Cardiac Imaging and Diagnostics (9 papers). Yannick Kaiser collaborates with scholars based in Netherlands, United States and United Kingdom. Yannick Kaiser's co-authors include Erik S.G. Stroes, Matthias Nahrendorf, Ahmed Tawakol, Richard A. P. Takx, Amorina Ishai, Jeffrey Kroon, Kang H. Zheng, Abdelrahman Ali, Quynh A. Truong and Amparo L. Figueroa and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Yannick Kaiser

33 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study

2017 420 citations Ahmed Tawakol, Amorina Ishai et al. The Lancet profile →
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

2022 99 citations Yannick Kaiser, Marwa Daghem et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yannick Kaiser Netherlands	18	495	402	183	173	164	34	1.2k
Amparo L. Figueroa United States	14	887 1.8×	505 1.3×	312 1.7×	518 3.0×	296 1.8×	24	2.0k
Kenji Kanazawa Japan	21	407 0.8×	413 1.0×	126 0.7×	100 0.6×	151 0.9×	69	1.5k
John P. Ryan United States	23	122 0.2×	319 0.8×	169 0.9×	69 0.4×	83 0.5×	105	1.7k
Bing‐Shen Huang Taiwan	23	274 0.6×	228 0.6×	37 0.2×	104 0.6×	63 0.4×	84	1.5k
Shmuel Tiosano Israel	24	118 0.2×	200 0.5×	236 1.3×	48 0.3×	171 1.0×	84	1.6k
Luis Caballero Spain	18	629 1.3×	165 0.4×	131 0.7×	52 0.3×	162 1.0×	50	1.6k
Mengye Guo United States	20	278 0.6×	340 0.8×	45 0.2×	233 1.3×	108 0.7×	26	1.6k
Eeva Ekholm Finland	25	510 1.0×	152 0.4×	52 0.3×	21 0.1×	173 1.1×	81	1.6k
Yong Lin United States	14	429 0.9×	246 0.6×	30 0.2×	35 0.2×	143 0.9×	29	1.4k
Bruce M. Elliott United States	19	126 0.3×	369 0.9×	63 0.3×	38 0.2×	79 0.5×	59	1.1k

Countries citing papers authored by Yannick Kaiser

Since Specialization

Citations

This map shows the geographic impact of Yannick Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Kaiser more than expected).

Fields of papers citing papers by Yannick Kaiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannick Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Kaiser. The network helps show where Yannick Kaiser may publish in the future.

Co-authorship network of co-authors of Yannick Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Yannick Kaiser. A scholar is included among the top collaborators of Yannick Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannick Kaiser. Yannick Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaiser, Yannick, Merel L. Hartgers, Aldo Grefhorst, et al.. (2024). Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study. Journal of the American Heart Association. 13(20). e035259–e035259. 2 indexed citations

Kraaijenhof, Jordan M, Nick S. Nurmohamed, Evangelos Tzolos, et al.. (2024). Interleukin 6 plasma levels are associated with progression of coronary plaques. Open Heart. 11(2). e002773–e002773. 3 indexed citations

Nurmohamed, Nick S., Michiel J. Bom, Yannick Kaiser, et al.. (2024). Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. JAMA Cardiology. 9(9). 826–826. 29 indexed citations

Zheng, Kang H., Yannick Kaiser, Nick S. Nurmohamed, et al.. (2024). First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectin. EJNMMI Research. 14(1). 112–112. 2 indexed citations

Kaiser, Yannick, Mia Ståhle, Nick S. Nurmohamed, et al.. (2023). Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes. Diabetologia. 66(11). 2164–2169. 8 indexed citations

Reeskamp, Laurens F., Yannick Kaiser, Merel L. Hartgers, et al.. (2023). Can human trans intestinal cholesterol excretion be stimulated using ursodeoxycholic acid and ezetimibe: A randomized placebo controlled cross-over study. Atherosclerosis. 379. S62–S62. 1 indexed citations

Botezatu, Simona, Evangelos Tzolos, Yannick Kaiser, et al.. (2023). Serum lipoprotein(a) and bioprosthetic aortic valve degeneration. European Heart Journal - Cardiovascular Imaging. 24(6). 759–767. 7 indexed citations

Kaiser, Yannick, Kim E. Dzobo, Madeline J. L. Ravesloot, et al.. (2022). Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apnea. Atherosclerosis. 344. 7–12. 5 indexed citations

Kaiser, Yannick, Marwa Daghem, Evangelos Tzolos, et al.. (2022). Association of Lipoprotein(a) With Atherosclerotic Plaque Progression. Journal of the American College of Cardiology. 79(3). 223–233. 99 indexed citations breakdown →

10.

Collard, Didier, Nick S. Nurmohamed, Yannick Kaiser, et al.. (2021). Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study. BMJ Open. 11(2). e045482–e045482. 28 indexed citations

11.

Kaiser, Yannick, Hasanga D. Manikpurage, Nicolas Perrot, et al.. (2021). Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic LPA Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational Analyses. Circulation Genomic and Precision Medicine. 14(4). e003271–e003271. 16 indexed citations

12.

Nurmohamed, Nick S., Didier Collard, Laurens F. Reeskamp, et al.. (2021). Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study. Atherosclerosis. 341. 43–49. 22 indexed citations

13.

Hoogeveen, Renate M., Simone L. Verweij, Yannick Kaiser, et al.. (2021). Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Scientific Reports. 11(1). 4126–4126. 5 indexed citations

14.

Wasiak, Sylwia, Kim E. Dzobo, Brooke D. Rakai, et al.. (2020). BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes. Clinical Epigenetics. 12(1). 166–166. 31 indexed citations

15.

Zheng, Kang H., Yannick Kaiser, Raúl D. Santos, et al.. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis. 311. 13–19. 23 indexed citations

16.

Zheng, Kang H., Benoît J. Arsenault, Yannick Kaiser, et al.. (2019). apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study. Journal of the American Heart Association. 8(16). e013020–e013020. 17 indexed citations

17.

Tawakol, Ahmed, Amorina Ishai, Richard A. P. Takx, et al.. (2017). Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. The Lancet. 389(10071). 834–845. 420 indexed citations breakdown →

18.

Valk, Fleur M. van der, Simone L. Verweij, Koos Zwinderman, et al.. (2016). Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging. JACC. Cardiovascular imaging. 9(10). 1198–1207. 75 indexed citations

19.

Valk, Fleur M. van der, Carlijn Kuijk, Simone L. Verweij, et al.. (2016). Increased haematopoietic activity in patients with atherosclerosis. European Heart Journal. 38(6). ehw246–ehw246. 74 indexed citations

20.

Kaiser, Yannick, et al.. (2016). Imaging High-Risk Atherosclerotic Plaques with PET. Current Treatment Options in Cardiovascular Medicine. 18(12). 76–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact